ARICKA KESIC-SELLERS: Open Payments
NPI 1518395466 · WADSWORTH, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$295 in 15 payments from 10 companies in 2025. Trend: 2023 $0 · 2024 $93 · 2025 $295
Food & beverage: $295
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $62 |
| Supernus Pharmaceuticals, Inc. | 2 | $55 |
| ABBVIE INC. | 2 | $40 |
| Neurocrine BioSciences, Inc. | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Sage Therapeutics, LLC | 1 | $20 |
| Janssen Pharmaceuticals, Inc | 1 | $18 |
| Alkermes, Inc. | 1 | $17 |
| E.R. Squibb & Sons, L.L.C. | 1 | $16 |
| Otsuka America Pharmaceutical, Inc. | 1 | $15 |
Products named: Qelbree, VRAYLAR, Auvelity, INGREZZA, Sunosi, AUSTEDO XR, ZURZUVAE, SPRAVATO.
Industry payments across OH — which companies pay providers there.
